The expression of cleaved-caspase 3 in romidepsin-treated group was also upregulated (Fig. 2b).In the CAC model, colon cancer was induced by AOM and 3% DSS treatment for 70 days and then treated with romidepsin three times (Fig. 2c). Here, CASP3 is linked to malignant colon neoplasm.